Charles River Labs, US1591881009

Charles River Labs stock heads into the open after a 1.4% dip

Published on 09/11/2026 at 08:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 8, 2026, Charles River Labs stock finished at 283.98 USD on the NYSE, down 1.4% for the session. The shares traded between 280.10 and 287.40 USD, while the Dow Jones slipped 0.8% the same day. Today, investors watch broader economic data.

Moderner CRO-Forschungscampus mit Glasfassade in Wilmington Massachusetts
Charles River Laboratories Forschungscampus in Wilmington Massachusetts, modernes Glaslaborgebäude, ISIN US1591881009, Außenansicht, Illustration mit AI erstellt.

Charles River Labs stock closed at 283.98 USD on the NYSE on September 8, 2026, losing 1.4% for the session per exchange data. The shares traded between 280.10 and 287.40 USD during that session, with volume in the hundreds of thousands of shares. On the same date the Dow Jones Industrial Average fell 0.8% to 52,380.66, so Charles River Labs moved broadly in line with the wider market according to a stock wrap by Zacks.

September 8, 2026 in numbers

Charles River Laboratories International, Inc. (ISIN US1591881009, NYSE: CRL) ended the September 8, 2026 session at 283.98 USD on the NYSE, compared with an average analyst target around 281 USD cited in recent coverage, so the close stood slightly above that reference level as noted by ad-hoc-news. The intraday range between roughly 280 USD and 287 USD placed the close within the upper half of the day’s band, and within the existing one year range between 144.26 USD and 303.30 USD mentioned in a recent institutional holding update from MarketBeat. That positioning leaves the stock below its one year high yet significantly above its one year low, underlining that the recent pullback of 1.4% on September 8, 2026 occurred within a still-elevated trading band.

Trading activity remained supported by institutional flows earlier in the week, including moves by asset managers that adjusted their exposure to Charles River Laboratories International, Inc. as documented by MarketBeat. While these filings relate to prior transactions rather than the September 8, 2026 tape itself, they frame the recent session close against a backdrop of portfolio rebalancing by large investors. Combined with the 0.8% decline of the Dow Jones Industrial Average on September 8, 2026, the 1.4% drop in Charles River Labs stock that day reflected both stock specific positioning and the broader risk-off tone in US equities reported by Zacks.

Today’s drivers and data

Today, September 11, 2026, no company specific release or scheduled earnings event for Charles River Laboratories International, Inc. appears on the major public earnings calendars, so attention turns to the broader macro backdrop for cues on the next NYSE session. The US earnings calendar for September 11, 2026 compiled by Yahoo Finance lists several reporting companies across health care and related sectors, whose guidance and commentary can influence sentiment toward contract research and laboratory service providers such as Charles River Labs. In addition, the performance of the Dow Jones Industrial Average and other major indices during today’s session will matter for the stock, given that its 1.4% decline on September 8, 2026 aligned closely with the 0.8% fall in the blue-chip index. Ahead of the opening bell on September 11, 2026, the reference level of 283.98 USD from the last completed NYSE session on September 8, 2026 serves as the main yardstick for investors watching how new earnings reports and economic data might reset valuations for Charles River Labs stock today.

Disclaimer...

en | US1591881009 | CHARLES RIVER LABS | boerse | 70085968 | bgmi